Sysmex ADR EBITDA 2016-2024 | SSMXY
Sysmex ADR annual and quarterly EBITDA history from 2016 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Sysmex ADR EBITDA for the quarter ending December 31, 2024 was $0.170B, a 38.78% increase year-over-year.
- Sysmex ADR EBITDA for the twelve months ending December 31, 2024 was $0.669B, a 14.82% increase year-over-year.
- Sysmex ADR 2024 annual EBITDA was $0.757B, a 3.05% decline from 2023.
- Sysmex ADR 2023 annual EBITDA was $0.781B, a 7.53% decline from 2022.
- Sysmex ADR 2022 annual EBITDA was $0.844B, a 21.11% increase from 2021.
| Sysmex ADR Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $757 |
| 2023 | $781 |
| 2022 | $844 |
| 2021 | $697 |
| 2020 | $727 |
| 2019 | $694 |
| 2018 | $691 |
| 2017 | $572 |
| 2016 | $630 |
| Sysmex ADR Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-06-30 | $170 |
| 2023-06-30 | $158 |
| 2022-06-30 | $142 |
| 2021-06-30 | $199 |
| 2020-06-30 | $122 |
| 2019-06-30 | $155 |
| 2018-06-30 | $162 |
| 2017-06-30 | $143 |
| 2016-06-30 | $160 |
| 2016-03-31 | $585 |
| 2015-12-31 | $524 |
| 2015-09-30 | $526 |
| 2015-06-30 | $478 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.284B | $3.340B |
| Sysmex Corporation is engaged in the development, manufacture, import, export and sale of clinical laboratory instruments, reagents and software used in -vitro diagnostics. It also provides clinical laboratory testing of blood, urine and other specimens. The company's product includes instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis and point-of-care testing. Its operating segment consists of Japan, Americas, EMEA, China and Asia Pacific. Sysmex Corporation is headquartered in Kobe, Japan. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $182.674B | 22.10 |
| Intuitive Surgical (ISRG) | United States | $168.441B | 69.82 |
| IDEXX Laboratories (IDXX) | United States | $50.647B | 52.71 |
| Edwards Lifesciences (EW) | United States | $47.649B | 31.58 |
| Alcon (ALC) | Switzerland | $39.055B | 26.22 |
| DexCom (DXCM) | United States | $31.616B | 47.42 |
| IQVIA Holdings (IQV) | United States | $31.516B | 17.81 |
| Mettler-Toledo (MTD) | United States | $26.326B | 31.25 |
| STERIS (STE) | Ireland | $24.376B | 25.94 |
| Waters (WAT) | United States | $17.288B | 23.75 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.986B | 0.00 |
| Hologic (HOLX) | United States | $14.940B | 16.19 |
| Penumbra (PEN) | United States | $9.803B | 71.61 |
| Globus Medical (GMED) | United States | $8.171B | 18.85 |
| Masimo (MASI) | United States | $7.836B | 26.37 |
| Teleflex (TFX) | United States | $5.507B | 8.89 |
| Glaukos (GKOS) | United States | $5.149B | 0.00 |
| TransMedics (TMDX) | United States | $4.050B | 61.56 |
| Integer Holdings (ITGR) | United States | $3.743B | 18.68 |
| LivaNova (LIVN) | United Kingdom | $2.886B | 16.52 |
| Alphatec Holdings (ATEC) | United States | $2.357B | 0.00 |
| Veracyte (VCYT) | United States | $2.315B | 31.99 |
| PROCEPT BioRobotics (PRCT) | United States | $2.189B | 0.00 |
| Artivion (AORT) | United States | $2.036B | 102.71 |
| Nihon Kohden (NHNKY) | Japan | $1.858B | 22.18 |
| Elekta AB (EKTAY) | Sweden | $1.858B | 17.38 |
| OPKO Health (OPK) | United States | $1.095B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.076B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.066B | 6.11 |
| IRadimed (IRMD) | United States | $0.897B | 43.54 |
| Tandem Diabetes Care (TNDM) | United States | $0.747B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.734B | 0.00 |
| AxoGen (AXGN) | United States | $0.729B | 0.00 |
| SiBone (SIBN) | United States | $0.675B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.575B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.518B | 9.15 |
| OrthoPediatrics (KIDS) | United States | $0.480B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.459B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.446B | 3.58 |
| Pacific Biosciences Of California (PACB) | United States | $0.378B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.369B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.368B | 9.36 |
| Delcath Systems (DCTH) | United States | $0.364B | 86.75 |
| RxSight (RXST) | United States | $0.357B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.291B | 0.00 |
| NeuroPace (NPCE) | United States | $0.285B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.283B | 19.54 |
| Alpha Tau Medical (DRTS) | Israel | $0.266B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.257B | 0.00 |
| Neuronetics (STIM) | United States | $0.224B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.222B | 0.00 |
| 908 Devices (MASS) | United States | $0.216B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.216B | 0.00 |
| Inogen (INGN) | United States | $0.204B | 0.00 |
| CVRx (CVRX) | United States | $0.198B | 0.00 |
| Accuray (ARAY) | United States | $0.176B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.162B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.157B | 0.00 |
| LENSAR (LNSR) | United States | $0.149B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.138B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.117B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.114B | 0.00 |
| InspireMD (NSPR) | United States | $0.099B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.096B | 0.00 |
| Hyperfine (HYPR) | United States | $0.096B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.071B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.061B | 0.00 |
| Positron (POSC) | United States | $0.058B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.051B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.050B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.038B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Vyome Holdings (HIND) | United States | $0.007B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.36 |